Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Recirculating Cooler/Chiller FL1203

Product Image
Product Description
The FL series offers a new generation of chillers for routine cooling applications within the laboratory and industry. The working temperature range covers –20°C to +40°C, the temperature stability of the PID control is ±0.5°C. All units can easily be cleaned and are provided with a splash water proof keypad with LED temperature indication. On the front of the units there is an RS232 interface as well as an alarm shutdown. The filling port is easily accessible placed on the top under a lift-up cover. Another hinged tray serves as a file for the operating manual or other documents concerning the installation. The removible venting grid allows an easy cleaning of the condenser, the drain tap is easily acceable behind the grid. All models include an easily visible level indication. Another advantage is the venting slots are on the front and rear and therefore the units can be placed directly one beside the other (space saving).
Product Recirculating Cooler/Chiller FL1203
Company Julabo Labortechnik
Price Request a quote
More Information View company product page
Catalog Number 9663012
Quantity Unspecified
Company Logo

Julabo Labortechnik
Eisenbahnstrasse 45 77960 Seelbach Germany

Tel: +49 7823 51190
Fax: +49 7823 2491

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos